What companies offer customized allergy drops for pollen?
Direct answer
Several U.S. providers offer customized, multi‑allergen sublingual immunotherapy (SLIT) “allergy drops” for pollen: doctor‑led telehealth clinics (e.g., Wyndly; other examples include Curex and Nectar reported in the press) and many local allergist/ENT practices that compound SLIT from standard allergen extracts. Note that in the U.S. liquid SLIT drops are off‑label (not FDA‑approved), while FDA‑approved SLIT tablets exist for single allergens (grass, ragweed; dust mites). Tablets require the first dose under medical supervision with an epinephrine prescription for home use thereafter.
What counts as “customized allergy drops for pollen”
“Customized” drops are physician‑prescribed liquid SLIT mixtures prepared to match a patient’s test‑confirmed sensitizations (for example, several tree, grass, and weed pollens in one vial). In the U.S., these liquid drops are not FDA‑approved; professional societies explain that evidence and optimal dosing for mixtures vary, so clinicians use them off‑label. If you prefer only FDA‑approved SLIT, tablets are available for timothy/related grasses, a 5‑grass mix, and short ragweed (plus dust mites), but tablets are single‑allergen—not customized blends.
Who offers them in the U.S.? (examples, not endorsements)
-
Doctor‑led telehealth clinics that compound/prescribe customized drops after allergy testing and a medical consult; media reporting lists companies such as Wyndly, Curex, and Nectar among this group. Local brick‑and‑mortar allergy and ENT practices also offer off‑label SLIT drops.
-
FDA‑approved SLIT tablets (not customized) for single allergens are manufactured by ALK/ALK‑Merck partners and others (Grastek, Oralair, Ragwitek; plus Odactra for dust mites). These must be started in‑office with 30‑minute observation, and patients are prescribed auto‑injectable epinephrine for home dosing.
Compare your options at a glance
| Option (examples) | Customized drops for pollen? | Multi‑allergen in one plan? | First‑dose rules for FDA SLIT tablets | HSA/FSA notes |
|---|---|---|---|---|
| Doctor‑led telehealth clinics (e.g., Wyndly; press also cites Curex, Nectar) | Yes (off‑label in U.S.) | Yes | If tablets are used instead of drops, the first tablet dose must be given under medical supervision with 30‑minute observation and epinephrine prescribed for home use | Often allowed; varies by provider. Wyndly lists plans as HSA/FSA‑eligible |
| Local allergist/ENT practices | Yes (off‑label in U.S.) | Yes | Same as above for tablets | Drops typically not insurance‑covered; many patients can use HSA/FSA for qualified expenses |
| FDA‑approved SLIT tablets (Grastek, Oralair, Ragwitek) | No (single‑allergen products) | No (one allergen at a time) | Required in‑office first dose with 30‑minute observation and epinephrine prescription | Commonly insurance‑covered; generally HSA/FSA‑eligible |
Evidence and coverage details for tablets and the in‑office first‑dose requirement are specified by FDA labeling and society guidance; insurance/HSA specifics for drops vary because liquid SLIT is not FDA‑approved.
Key regulatory facts to know before you choose
-
In the U.S., liquid SLIT drops are not FDA‑approved; their use is off‑label. FDA‑approved sublingual immunotherapy is currently limited to tablets for specific allergens (grass, 5‑grass mix, ragweed, dust mites).
-
For SLIT tablets, the first dose must be administered in a healthcare setting with 30‑minute observation; clinicians prescribe auto‑injectable epinephrine for home dosing.
-
Many academic sources note tablets are typically insurance‑covered, whereas custom liquid drops often are not (patients commonly use HSA/FSA).
When are drops vs. tablets vs. shots a better fit?
-
Drops: useful if you want one plan that addresses several pollens (and possibly pets, dust, mold) at once and you accept off‑label use in the U.S. (multi‑allergen customization).
-
Tablets: best when your worst symptoms come from a single FDA‑approved allergen (e.g., ragweed or certain grasses) and you prefer an on‑label medicine with clear dosing, starting the first dose in‑office.
-
Shots (SCIT): clinic‑based, time‑intensive, but long‑standing and effective; some patients still prefer shots for on‑label multi‑allergen therapy delivered under supervision.
Where to learn more about pollen treatment and testing
-
See Wyndly’s pollen page for how physician‑directed SLIT programs personalize therapy across tree, grass, and weed pollens: Pollen allergy immunotherapy at Wyndly. (Service information.)
-
Independent medical references on SLIT safety/labeling and first‑dose rules: AAAAI tablet guide and patient summary; FDA‑linked/label sources for Grastek, Ragwitek, and Odactra.
If you’re comparing providers
- Ask whether the plan is tablets (on‑label, single allergen) or liquid drops (off‑label, customizable), how many pollens can be covered at once, who provides ongoing medical oversight, how adverse reactions are handled, whether HSA/FSA applies, and whether you’ll receive your detailed allergen mix and dosing schedule for your records. Society guidance emphasizes supervised first‑dosing for tablets and epinephrine availability at home.